Becton Dickinson
Trade Becton Dickinson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BDX
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional.
BDX Key Statistics
Stock Snapshot
As of today, Becton Dickinson(BDX) shares are valued at $200.95. The company's market cap stands at 57.92B, with a P/E ratio of 34.54 and a dividend yield of 2.1%.
On 2025-12-15, Becton Dickinson(BDX) stock traded between a low of $198.40 and a high of $202.75. Shares are currently priced at $200.95, which is +1.3% above the low and -0.9% below the high.
The Becton Dickinson(BDX)'s current trading volume is 2.49M, compared to an average daily volume of 1.78M.
During the past year, Becton Dickinson(BDX) stock moved between $162.29 at its lowest and $251.99 at its peak.
During the past year, Becton Dickinson(BDX) stock moved between $162.29 at its lowest and $251.99 at its peak.
BDX News
Recent moves in Becton Dickinson (BDX) have been driven by two MedTech updates: a global rollout of next generation cell analyzers and a new ChemoGLO alliance f...
In recent trading, shares of Becton, Dickinson & Co (Symbol: BDX) have crossed above the average analyst 12-month target price of $200.40, changing hands for $2...